BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27617989)

  • 1. Comparison of Protein N-Homocysteinylation in Rat Plasma under Elevated Homocysteine Using a Specific Chemical Labeling Method.
    Zang T; Pottenplackel LP; Handy DE; Loscalzo J; Dai S; Deth RC; Zhou ZS; Ma J
    Molecules; 2016 Sep; 21(9):. PubMed ID: 27617989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma protein homocysteinylation in hemodialysis patients.
    Perna AF; Satta E; Acanfora F; Lombardi C; Ingrosso D; De Santo NG
    Kidney Int; 2006 Mar; 69(5):869-76. PubMed ID: 16395265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-homocysteinylation of transthyretin is detected in plasma and serum of humans with different types of hyperhomocysteinemia.
    Sass JO; Nakanishi T; Sato T; Sperl W; Shimizu A
    Biochem Biophys Res Commun; 2003 Oct; 310(1):242-6. PubMed ID: 14511677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels.
    Jakubowski H
    FASEB J; 1999 Dec; 13(15):2277-83. PubMed ID: 10593875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine targeting of plasma proteins in hemodialysis patients.
    Jacobsen DW
    Kidney Int; 2006 Mar; 69(5):787-9. PubMed ID: 16518339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Homocysteinylation impairs collagen cross-linking in cystathionine β-synthase-deficient mice: a novel mechanism of connective tissue abnormalities.
    Perła-Kajan J; Utyro O; Rusek M; Malinowska A; Sitkiewicz E; Jakubowski H
    FASEB J; 2016 Nov; 30(11):3810-3821. PubMed ID: 27530978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
    Jakubowski H
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processes of plasma protein N-homocysteinylation in multiple sclerosis.
    Jamroz-Wiśniewska A; Bełtowski J; Bartosik-Psujek H; Wójcicka G; Rejdak K
    Int J Neurosci; 2017 Aug; 127(8):709-715. PubMed ID: 27671515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effect of homocysteine in the reduced form, its thiolactone and protein homocysteinylation on hemostatic properties of plasma.
    Malinowska J; Nowak P; Olas B
    Thromb Res; 2011 Mar; 127(3):214-9. PubMed ID: 21186049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of paraoxonase 1 (PON1) activity and protein N-homocysteinylation by bisphosphonates in rats.
    Rusek M; Pastryk JE; Bełtowski J
    Chem Biol Interact; 2016 Nov; 259(Pt B):401-406. PubMed ID: 27387541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein homocysteinylation: a new mechanism of atherogenesis?
    Bełtowski J
    Postepy Hig Med Dosw (Online); 2005; 59():392-404. PubMed ID: 16106241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-homocysteinylation of tau and MAP1 is increased in autopsy specimens of Alzheimer's disease and vascular dementia.
    Bossenmeyer-Pourié C; Smith AD; Lehmann S; Deramecourt V; Sablonnière B; Camadro JM; Pourié G; Kerek R; Helle D; Umoret R; Guéant-Rodriguez RM; Rigau V; Gabelle A; Sequeira JM; Quadros EV; Daval JL; Guéant JL
    J Pathol; 2019 Jul; 248(3):291-303. PubMed ID: 30734924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma protein homocysteinylation in uremia.
    Perna AF; Acanfora F; Luciano MG; Pulzella P; Capasso R; Satta E; Cinzia L; Pollastro RM; Iannelli S; Ingrosso D; De Santo NG
    Clin Chem Lab Med; 2007; 45(12):1678-82. PubMed ID: 17937608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of genetic factors in the development of hyperhomocysteinemia.
    Geisel J; Hübner U; Bodis M; Schorr H; Knapp JP; Obeid R; Herrmann W
    Clin Chem Lab Med; 2003 Nov; 41(11):1427-34. PubMed ID: 14656021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of homocysteine in protein quality control processes.
    Reddy VS; Trinath J; Reddy GB
    Biochimie; 2019 Oct; 165():19-31. PubMed ID: 31269461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct monitoring of albumin lysine-525 N-homocysteinylation in human serum by liquid chromatography/mass spectrometry.
    Sikora M; Marczak L; Twardowski T; Stobiecki M; Jakubowski H
    Anal Biochem; 2010 Oct; 405(1):132-4. PubMed ID: 20659604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregation and structural changes of α(S1)-, β- and κ-caseins induced by homocysteinylation.
    Stroylova YY; Zimny J; Yousefi R; Chobert JM; Jakubowski H; Muronetz VI; Haertlé T
    Biochim Biophys Acta; 2011 Oct; 1814(10):1234-45. PubMed ID: 21689790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disturbance of hemostasis induced by hyperhomocysteinemia; the role of antioxidants.
    Malinowska J; Kolodziejczyk J; Olas B
    Acta Biochim Pol; 2012; 59(2):185-94. PubMed ID: 22577622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase 1 protects against protein N-homocysteinylation in humans.
    Perla-Kaján J; Jakubowski H
    FASEB J; 2010 Mar; 24(3):931-6. PubMed ID: 19880629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural changes of fibrinogen molecule mediated by the N-homocysteinylation reaction.
    Genoud V; Quintana PG; Gionco S; Baldessari A; Quintana I
    J Thromb Thrombolysis; 2018 Jan; 45(1):66-76. PubMed ID: 29075923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.